1. Suh R. Presentation of evaluation findings (draft). Rockville, MD: Agency for Healthcare Research and Quality; 2005.
2. Johnson A. Measuring DM's net effect is harder than you might think. Manag Care 2003 June;12(6):28-32.
3. Williams C. Medicaid disease management: issues and promises. Kaiser Commission on Medicaid and the Uninsured. Washington, DC: Kaiser Family Foundation; September 2004.
4. Letter to State Medicaid Directors, Baltimore, MD: Centers for Medicare & Medicaid Services, 2004 Feb 25.
5. Health Strategies Consultancy. Disease management in Medicaid. Oakland, CA: California HealthCare Foundation, 2004.
6. Leatherman S, Berwick D, Iles D, et al. The business case for quality: case studies and an analysis. Health Aff 2003 March-April; 22(2):17-30.
7. Holtz-Eakin D. An analysis of the literature on disease management programs. Washington, DC: Congressional Budget Office; 2004.
8. Goetzel RZ, Ozminkowski RJ, Villagra VG, et al. Return on investment in disease management: a review. Health Care Financ Rev 2005;26:1-19.
9. Glabman M. 'Take my word for it': the enduring dispute over measuring dm's economic value. Manag Care Mag Apr 2006. Available at: http://www.managedcaremag.com/archives/0604/0604.dmvalue.html. Accessed December 10, 2007.
10. Chang D, Burton A, O'Brien J, et al. Honesty as good policy: evaluating maryland's medicaid managed care program. Milbank Q 2003;81(3):389-414.
11. Wallace P. Is there long-term value in programs? Reflections on the 2004 CBO report. The Disease Management Colloquium. Philadelphia: Jefferson Medical College; 2005 June 22.
12. Lind A. Department of Social and Health Services, Washington State. Personal communication; March 17, 2006.
13. Vann C. Texas Health and Human Services Commission. Personal communication; March 26, 2006.
14. Suchman E. Evaluation research: principles and practice in public service and social action programs. New York: Russell Sage College; 1967.
15. Consumer Assessment of Healthcare Providers and Systems. Rockville, MD: Agency for Healthcare Research and Quality. Available at https://cahps.ahrq.gov. Accessed October 19, 2007.
16. Rosenman M, Holmes A, Ackermann R, et al. The Indiana chronic disease management program. Milbank Q 2006;84(1):135-63.
17. Congressional Budget Office. An analysis of the literature on disease management programs. Washington, DC: Government Printing Office; 2004.
18. Fitzner K, Sidorov J, Fetterolf D, et al. Principles for assessing disease management outcomes. Dis Manag 2004;7(3):191-201.
19. Christakis D, Connell F, Richardson A, et al. Report of disease management evaluation. Seattle, WA: University of Washington; 2004.
20. Lawson K. Virginia Department of Medical Assistance Services. Personal communication; March 29, 2006.
21. Hewson D. Community Care of North Carolina. Personal communication; October 12 2006 and March 16, 2007.
22. Morgan J. Pennsylvania Office of Medical Assistance Programs. Personal communication; March 6, 2006.
23. Blueprint for Health. Burlington, VT: Vermont Department of Health; 2005. Available at http://healthvermont.gov/blueprint.aspx. Accessed December 10, 2007.
25. North Carolina Area Health Education Centers. Chapel Hill, NC: North Carolina AHEC Program. Available at http://www.ncahec.net. Accessed December 10, 2007.
25. Inui T. Regenstief Institute, Indianapolis, IN. Personal communication; March 8, 2006.
26. Rosenman M, Holmes A, Ackermann R, et al. The Indiana Chronic Disease Management Program. Milbank Q 2006;84(1):135-63.
27. Lind A, Kaplan L, Berg G. Evaluation of an asthma disease management program in a Medicaid population. Dis Manag 2006;14(3):151-61.
28. Gold MR, Siegel JE, Russell, et al, eds. Cost-effectiveness in health and medicine. Chicago, IL: Health Administration Press; 1996.
29. Rossi PH, Lipsey MW, Freeman HE. Evaluation: a systematic approach. Thousand Oaks, CA: Sage Publications, 2003.
30. Veney JE, Kaluzny, AD. Evaluation and decision making for health services programs. Englewood Cliffs, NJ: Prentice Hall; 1998.
31. Wilson T. Evaluating ROI in State disease management programs. Issue Brief, State Coverage Initiatives. Washington, DC: AcademyHealth; 2003.
32. Fetterolf D, Wennberg D, DeVries A. Estimating the return on investment in disease management programs using a pre-post analysis. Dis Manag 2004 Spring;7(1):5-23.
33. Evaluation of Community Care of North Carolina asthma and diabetes management initiatives: January 2000-December 2002. Raleigh, NC: NC Foundation for Advanced Health Programs, Inc; 2004. Available at: http://www.communitycarenc.com/PDFDocs/Sheps%20Eval.pdf. Accessed December 10, 2007.
34. Linden A, Adams JL, Roberts N. Evaluation methods in disease management: determining program effectiveness. Washington, DC: Disease Management Association of America; 2006. Available at http://www.dmaa.org/pdf/Evaluation_Methods_in_DM.pdf. Accessed December 10, 2007.
35. Family and Children's Health Programs Group, Center for Medicaid and State Operations. The guide to quality measures: a compendium. Medicaid and SCHIP quality improvement, Volume 1.0. Baltimore, MD: Centers for Medicare & Medicaid Services; Sept 2006. Available at http://www.cms.hhs.gov/MedicaidSCHIPQualPrac/Downloads/pmfinalaugust06.pdf. Accessed December 10, 2007.
36. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR-3). Rockville, MD: National Institutes of Health; July 2007. Available at http://www.nhlbi.nih.gov/guidelines/asthma. Accessed December 10, 2007.
37. American Diabetes Association clinical practice recommendations, 2007. Diabetes Care 2007;1(Suppl 30). Available at http://www.diabetes.org/for-health-professionals-and-scientists/cpr.jsp. Accessed December 10, 2007.
Return to Contents
Proceed to Appendix 1